The Importance of Reporting Negative Findings in Data Mining-Reference-Cited by-同舟云学术

The Importance of Reporting Negative Findings in Data Mining

Published:2008-07 Issue:4 Volume:22 Page:215-219
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Hauben Manfred,Hochberg Alan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF03256706.pdf

Reference16 articles.

1. Gould AL. Practical pharmacovigilance strategies. Pharmacoepidemiol Drug Saf 2003; 12: 559–74

2. Hauben M, Madigan D, Gerrits C, et al. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005; 4 (5): 929–48

3. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007 Jul 11; 298 (2): 194–206

4. US Food and Drug Administration. Exenatide (marketed as Byetta) information [online]. Available from URL: http://www.fda.gov/cder/drug/infopage/exenatide/default.htm [Accessed 2007 Nov 2]

5. Hauben M, Reich L. Communication of findings in pharmacovigilance: use of the term “signal” and the need for precision in its use. Eur J Clin Pharmacol 2005 Jul; 61 (5–6): 479–80

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When More Is Less: An Exploratory Study of the Precautionary Reporting Bias and Its Impact on Safety Signal Detection;Clinical Pharmacology & Therapeutics;2017-10-25

2. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database;Drug Safety;2017-07-05

3. Does serious consequential masking exist? An update;Pharmacoepidemiology and Drug Safety;2017-06

4. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases;Pharmacoepidemiology and Drug Safety;2013-11-15

5. Adverse Reaction Signaling and Disproportionality Analysis: An Update;Drug Information Journal;2012-11